Go to main website
Sensus Healthcare - Logo

Press Releases

Sensus Healthcare Expands International Business to Meet Rising Patient Demand for Non-Invasive Skin Cancer and Keloid Treatments

EVP Rick Golin Assumes New Role Bringing Superficial Radiation Therapy to International Distributors in Asia, the Americas, Europe and the Middle East BOCA RATON, Fla., April 19, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced […]
READ MORE

Sensus Healthcare to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

BOCA RATON, Fla., March 8, 2018 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and multi-platform state of the art aesthetic lasers, today announced the Company will present at the B. Riley FBR Inaugural China Healthcare Investing […]
READ MORE

Sensus Healthcare Launches New Line of Laser Systems to Provide Patients with Full Spectrum of Clinical and Aesthetic Dermatological Solutions

Lasers Address Acne Lesion Correction, Hair Removal and Tattoo Removal, Among Other Applications BOCA RATON, Fla., March 5, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today that the Company has launched Sensus Laser Systems, […]
READ MORE

Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe

BOCA RATON, Fla., Feb. 7, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today that the Company is opening a new office in Tel Aviv to deepen its presence in Israel, the Middle East and […]
READ MORE

Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World

BOCA RATON, Fla., Feb. 5, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today Sensus' collaboration with BirchBioMed Inc., a biomedical company focused on anti-scarring drugs, to treat and prevent scarring more effectively for patients […]
READ MORE

Sensus Healthcare Reports Record Revenue for 2017 Fourth Quarter and Full Year

Ninth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 1, 2018 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the three […]
READ MORE

Get notified about Sensus Healthcare

Get Email Alerts
Sensus Healthcare - Logo - Footer
Sensus Healthcare partners with The Pinnacle Health Group to provide reimbursement support for all customers. Please contact Pinnacle for support by phone at 866-369-9290 or email at [email protected] Hotline consultants are available Monday through Friday from 8:30 AM to 6:00 PM EST.
Contact Us
Sensus Healthcare World Headquarters:

851 Broken Sound Parkway
Boca Raton, FL 33487
[email protected]

Phone 561.922.5808
Toll-free 800.324.9890
Fax 561.948.2071
© Copyright 2023. Sensus Healthcare - All Rights Reserved.